Author: Ben Adams

NICE is recommending InterMune’s Esbriet for certain people who have the chronic lung condition idiopathic pulmonary fibrosis.

NICE is recommending Novartis’ asthma drug Xolair as a cost effective treatment for young children and adults with a severe form of the condition in England.

Nurses in the NHS believe the reforms to nursing in the health service are ‘stupid’ and are concerned about dwindling staff numbers.

NICE has given a provisional green light for Bayer’s blood thinner Xarelto for help patients with thrombotic events.

GlaxoSmithKline is being accused of undertaking unfair ‘pay-for-delay’ delays with several generics firms in the UK over the sale of copycat forms of its drug Seroxat.